IS2182B - Síprasídón samsetningar - Google Patents

Síprasídón samsetningar

Info

Publication number: IS2182B
Authority: IS; Iceland
Prior art keywords: ziprasidone; formulations; ziprasidone formulations
Prior art date: 1998-06-15

Application number

IS5079A

Other languages

English (en)

Other versions

IS5079A (is

Inventor

Roberts Busch Frank

Carol Gatlin Hausberger Angela

Rasadi Bijan

Ray Arenson Daniel

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-15

Filing date

1999-06-11

Publication date

2006-12-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22216447&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS2182(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-06-11 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

1999-12-16 Publication of IS5079A publication Critical patent/IS5079A/is

2006-12-15 Publication of IS2182B publication Critical patent/IS2182B/is

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Organic Chemistry (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Feeding Of Articles By Means Other Than Belts Or Rollers (AREA)
Polyamides (AREA)
Detergent Compositions (AREA)

IS5079A 1998-06-15 1999-06-11 Síprasídón samsetningar IS2182B (is)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US8922998P	1998-06-15	1998-06-15

Publications (2)

Publication Number	Publication Date
IS5079A IS5079A (is)	1999-12-16
IS2182B true IS2182B (is)	2006-12-15

Family

ID=22216447

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5079A IS2182B (is)	1998-06-15	1999-06-11	Síprasídón samsetningar

Country Status (44)

Country	Link
US (1)	US6150366A (is)
EP (1)	EP0965343B1 (is)
JP (2)	JP3441676B2 (is)
KR (1)	KR100338915B1 (is)
CN (1)	CN1307994C (is)
AP (1)	AP1216A (is)
AR (1)	AR015553A1 (is)
AT (1)	ATE240732T1 (is)
AU (1)	AU753820B2 (is)
BG (1)	BG64691B1 (is)
BR (1)	BR9902268A (is)
CA (1)	CA2274338C (is)
CO (1)	CO5070579A1 (is)
CY (1)	CY2003002I1 (is)
CZ (1)	CZ297954B6 (is)
DE (1)	DE69908021T2 (is)
DK (1)	DK0965343T3 (is)
EA (1)	EA002223B1 (is)
ES (1)	ES2197581T3 (is)
GT (1)	GT199900080A (is)
HN (1)	HN1999000089A (is)
HR (1)	HRP990193B1 (is)
HU (1)	HU226487B1 (is)
ID (1)	ID23546A (is)
IL (1)	IL130424A (is)
IS (1)	IS2182B (is)
MA (1)	MA26647A1 (is)
MY (1)	MY121397A (is)
NO (1)	NO316713B1 (is)
NZ (1)	NZ336271A (is)
OA (1)	OA11064A (is)
PA (1)	PA8475601A1 (is)
PE (1)	PE20000632A1 (is)
PL (2)	PL195209B1 (is)
PT (1)	PT965343E (is)
RS (1)	RS49611B (is)
SG (1)	SG77243A1 (is)
SI (1)	SI0965343T1 (is)
SK (1)	SK286245B6 (is)
TR (1)	TR199901379A2 (is)
TW (1)	TW590774B (is)
UA (1)	UA59383C2 (is)
UY (1)	UY25649A1 (is)
ZA (1)	ZA993938B (is)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20080113025A1 (en) *	1998-11-02	2008-05-15	Elan Pharma International Limited	Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
EA003907B1 (ru) *	1999-05-27	2003-10-30	Пфайзер Продактс Инк.	Композиция зипразидона в виде суспензии
US7175855B1 (en) *	1999-05-27	2007-02-13	Pfizer Inc.	Ziprasidone suspension
US10179130B2 (en)	1999-10-29	2019-01-15	Purdue Pharma L.P.	Controlled release hydrocodone formulations
KR100889069B1 (ko)	1999-10-29	2009-03-17	유로-셀티크 소시에떼 아노뉨	서방성 하이드로코돈 제형
BR0115382A (pt)	2000-10-30	2003-09-16	Euro Celtique Sa	Formulações para liberação controlada de hidrocodona, método de produzir analgesia efetiva, processo de preparação de uma forma farmacêutica de um sólido oral de liberação controlada, liberação controlada da forma farmacêutica oral e uso da forma farmacêutica
UY27668A1 (es) *	2002-02-20	2003-10-31	Pfizer Prod Inc	Composición de ziprasidona y controles sintéticos
US20040048876A1 (en) *	2002-02-20	2004-03-11	Pfizer Inc.	Ziprasidone composition and synthetic controls
EP2301537A1 (en) *	2002-05-17	2011-03-30	Duke University	Zonisamide for the treatment of obesity
AU2003300814A1 (en) *	2002-12-04	2004-06-23	Dr. Reddy's Laboratories Inc.	Polymorphic forms of ziprasidone and its hydrochloride
WO2004050655A1 (en) *	2002-12-04	2004-06-17	Dr. Reddy's Laboratories Limited	Polymorphic forms of ziprasidone and its hydrochloride
US20050143396A1 (en) *	2003-04-11	2005-06-30	Hertero Drugs Limited	Novel crystalline forms of ziprasidone hydrochloride
MXPA05011557A (es) *	2003-04-29	2006-03-09	Orexigen Therapeutics Inc	Composiciones para afectar perdida de peso.
WO2005035531A1 (en) *	2003-06-03	2005-04-21	Teva Paharmaceutical Industries Ltd.	POLYMORPHIC FORMS OF ZIPRASIDONE HCl AND PROCESSES FOR THEIR PREPARATION
US20050049295A1 (en) *	2003-06-12	2005-03-03	Dr. Reddy's Laboratories Limited	Process for the preparation of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1piperazinyl) ethyl)-6-chloro-1, 3-dihydro-2h-indol-2-one hydrochloride (ziprasidone hydrochloride) and its intermediate
BRPI0414082A (pt) *	2003-09-02	2006-10-24	Pfizer Prod Inc	formas de dosagem de liberação sustentada de ziprasidona
US7667037B2 (en) *	2003-10-24	2010-02-23	Teva Pharmaceutical Industries Ltd.	Processes for preparation of ziprasidone
WO2005054235A1 (en) *	2003-11-28	2005-06-16	Wockhardt Limited	Process for the preparing ziprasidone monohydrochloride hydrate
CN1934108A (zh)	2003-12-18	2007-03-21	特瓦制药工业有限公司	齐拉西酮碱的多晶型b2
WO2005065660A2 (en) *	2003-12-31	2005-07-21	Alpharma, Inc.	Ziprasidone formulations
US7713959B2 (en) *	2004-01-13	2010-05-11	Duke University	Compositions of an anticonvulsant and mirtazapine to prevent weight gain
JP2007517901A (ja) *	2004-01-13	2007-07-05	デューク・ユニバーシティー	体重の減少に作用する鎮痙剤及び抗精神病剤の組成物
PT1720867E (pt) *	2004-02-27	2010-01-28	Ranbaxy Lab Ltd	Processo para a preparação de ziprasidona
CA2565154A1 (en) *	2004-05-03	2005-11-24	Duke University	Compositions for affecting weight loss
WO2005107719A2 (en) *	2004-05-06	2005-11-17	Sandoz Ag	Pharmaceutical composition comprising hydrophobic drug having improved solubility
CA2467538C (en) *	2004-05-14	2010-08-24	Apotex Pharmachem Inc.	New amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol-2-one hydrochloride) and processes to produce the same
WO2005123086A2 (en) *	2004-06-11	2005-12-29	Dr. Reddy's Laboratories Ltd.	Ziprasidone dosage form
CA2471219A1 (en) *	2004-06-14	2005-12-14	Apotex Pharmachem Inc.	Improved preparation of an anhydrate form of 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol-2-one hydrochloride (ziprasidone hydrochloride)
US9044503B2 (en) *	2004-08-27	2015-06-02	University Of Kentucky Research Foundation	Amyloid peptide inactivating enzyme to treat alzheimer's disease peripherally
US20090142404A1 (en)	2004-08-31	2009-06-04	Pfizer Inc	Pharmaceutical dosage forms comprising a low-solubility drug and a polymer
EA200701065A1 (ru) *	2004-11-16	2007-12-28	Элан Фарма Интернэшнл Лтд.	Инъецируемые составы, содержащие нанодисперсный оланзапин
US20080268034A1 (en) *	2005-01-07	2008-10-30	Girish Karanth	Solid Oral Dosage Forms of Ziprasidone Containing Colloidal Silicone Dioxide
US7749529B2 (en) *	2005-02-08	2010-07-06	Ash Access Technology, Inc.	Catheter lock solution comprising citrate and a paraben
US20070032511A1 (en) *	2005-02-11	2007-02-08	Judith Aronhime	Amorphous ziprasidone mesylate
ITMI20050346A1 (it)	2005-03-07	2006-09-08	Dipharma Spa	Forma solida di ziprasidone cloridrato
CA2500667C (en) *	2005-03-11	2013-01-15	Apotex Pharmachem Inc.	Preparation of acid addition salts of ziprasidone and intermediates thereof by solid phase-gas phase reactions
US20060270685A1 (en) *	2005-03-14	2006-11-30	Judith Aronhime	Anhydrous ziprasidone mesylate and a process for its preparation
EP1858891A2 (en) *	2005-03-14	2007-11-28	Teva Pharmaceutical Industries Ltd.	Crystalline forms of ziprasidone mesylate
NZ561950A (en) *	2005-04-13	2010-09-30	Pfizer Prod Inc	Injectable depot formulations comprising ziprasidone in nanoparticle form with two surface stabilizers
US20080305161A1 (en) *	2005-04-13	2008-12-11	Pfizer Inc	Injectable depot formulations and methods for providing sustained release of nanoparticle compositions
AR056321A1 (es) *	2005-04-22	2007-10-03	Wyeth Corp	COMBINACIONES TERAPÉUTICAS PARA EL TRATAMIENTO O LA PREVENCIoN DE TRASTORNOS PSICoTICOS
DK2422783T3 (en)	2005-05-26	2015-05-11	Sumitomo Dainippon Pharma Co Ltd	pharmaceutical composition
MX2007016151A (es) *	2005-06-20	2008-03-06	Elan Pharma Int Ltd	Composiciones de liberacion controlada y en forma de nano-particulas que comprenden compuestos aril-heterociclicos.
EP1901722A4 (en) *	2005-06-20	2011-06-15	Elan Pharma Int Ltd	NANOTEHOUS COMPOSITIONS WITH CONTROLLED RELEASE FROM ARYL-HETEROCYCLIC COMPOUNDS
JP5180092B2 (ja)	2005-11-22	2013-04-10	オレキシジェン・セラピューティクス・インコーポレーテッド	インスリン感受性を増すための組成物および方法
ATE547097T1 (de) *	2005-11-28	2012-03-15	Orexigen Therapeutics Inc	Zonisamid-formulierung mit verzögerter freisetzung
PL379569A1 (pl) *	2006-04-28	2007-10-29	Pliva Kraków Zakłady Farmaceutyczne Spółka Akcyjna	Sposób wytwarzania kompozycji farmaceutycznej zawierającej substancję aktywną ziprasidone lub jego farmaceutycznie dopuszczalną sól zwiększający rozpuszczalność i biodostępność tego leku, kompozycja farmaceutyczna i zastosowanie hydrofilowych substancji pomocniczych
US8916195B2 (en)	2006-06-05	2014-12-23	Orexigen Therapeutics, Inc.	Sustained release formulation of naltrexone
EP1892243A1 (en) *	2006-08-02	2008-02-27	KRKA, tovarna zdravil, d.d., Novo mesto	Polymorphic forms of ziprasidone sulphate salts
EP1889844A3 (en) *	2006-08-02	2008-03-05	Krka	Polymorphic forms of ziprasidone sulphates
MX343867B (es)	2006-11-09	2016-11-25	Orexigen Therapeutics Inc	Paquete de dosificacion unitaria y metodos para administrar medicaciones de perdida de peso.
KR101654176B1 (ko)	2006-11-09	2016-09-09	오렉시젠 세러퓨틱스 인크.	신속하게 용해되는 중간층을 포함하는 층상의 약제학적 제형
JP2010527925A (ja) *	2007-05-18	2010-08-19	サイドース・エルエルシー	ジプラシドン製剤
EP2197446A4 (en) *	2007-08-31	2012-01-25	Reddys Lab Ltd Dr	PREPARATION OF HYDROCHLORIDE OF ZIPRASIDONE MONOHYDRATE
US8410268B2 (en) *	2008-03-11	2013-04-02	Alkem Laboratories Limited	Process for the preparation of ziprasidone
MX2010012909A (es)	2008-05-30	2011-02-25	Orexigen Therapeutics Inc	Metodos para tratamiento de condiciones de grasa visceral.
DE102008045854A1 (de)	2008-09-05	2010-03-11	Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg	Partikel aus Ziprasidone und einem Sprengmittel enthaltende Pharmazeutische Zusammensetzung
EP2445343B1 (en) *	2009-06-25	2021-08-04	Alkermes Pharma Ireland Limited	Prodrugs of nh-acidic compounds
EP2340834A1 (en)	2009-12-30	2011-07-06	Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi	Enhanced Solubility of Ziprasidone
EP2523557B1 (en)	2010-01-11	2019-09-25	Nalpropion Pharmaceuticals, Inc.	Methods of providing weight loss therapy in patients with major depression
JP5846647B2 (ja)	2010-02-25	2016-01-20	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	アピキサバン製剤
US20130108701A1 (en)	2010-05-25	2013-05-02	Krishna Murthy Bhavanasi	Solid Dosage Forms of Antipsychotics
SI23610A (sl)	2011-01-13	2012-07-31	Diagen@d@o@o	Nove adicijske soli ziprasidona postopek za njihovo pripravo in njihova uporaba v terapiji
PL4104824T3 (pl)	2012-06-06	2025-11-12	Nalpropion Pharmaceuticals Llc	Kompozycja do zastosowania w sposobie leczenia nadwagi i otyłości u pacjentów z wysokim ryzykiem sercowo-naczyniowym
EP3610890A1 (en)	2012-11-14	2020-02-19	The Johns Hopkins University	Methods and compositions for treating schizophrenia
US11273158B2 (en)	2018-03-05	2022-03-15	Alkermes Pharma Ireland Limited	Aripiprazole dosing strategy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5264446A (en) *	1980-09-09	1993-11-23	Bayer Aktiengesellschaft	Solid medicament formulations containing nifedipine, and processes for their preparation
MX173362B (es) *	1987-03-02	1994-02-23	Pfizer	Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
US4883795A (en) *	1988-01-22	1989-11-28	Pfizer Inc.	Piperazinyl-heterocyclic compounds
US4831031A (en) *	1988-01-22	1989-05-16	Pfizer Inc.	Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
DE4141268A1 (de) *	1991-12-14	1993-06-17	Merck Patent Gmbh	Pharmazeutische zubereitung
US5338846A (en) *	1992-08-26	1994-08-16	Pfizer Inc.	Process for preparing aryl piperazinyl-heterocyclic compounds with a piperazine salt
US5312925A (en) *	1992-09-01	1994-05-17	Pfizer Inc.	Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride
US5206366A (en) *	1992-08-26	1993-04-27	Pfizer Inc.	Process for preparing aryl piperazinyl-heterocyclic compounds
US5359068A (en) *	1993-06-28	1994-10-25	Pfizer Inc.	Processes and intermediates for the preparation of 5-[2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]-6-chloro-1,3-dihydro-indol-2-one
PT790236E (pt) *	1996-02-13	2004-04-30	Pfizer	Pro-farmacos de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil-6-cloro-1,3-di-hidro-2h-indol-2-ona
PT901786E (pt) *	1997-08-11	2007-08-07	Pfizer Prod Inc	Disperções farmacêuticas sólidas com biodisponibilidade melhorada

1999
- 1999-05-27 US US09/320,985 patent/US6150366A/en not_active Expired - Lifetime
- 1999-06-04 HN HN1999000089A patent/HN1999000089A/es unknown
- 1999-06-08 GT GT199900080A patent/GT199900080A/es unknown
- 1999-06-08 DK DK99304451T patent/DK0965343T3/da active
- 1999-06-08 ES ES99304451T patent/ES2197581T3/es not_active Expired - Lifetime
- 1999-06-08 EP EP99304451A patent/EP0965343B1/en not_active Expired - Lifetime
- 1999-06-08 SI SI9930316T patent/SI0965343T1/xx unknown
- 1999-06-08 PT PT99304451T patent/PT965343E/pt unknown
- 1999-06-08 DE DE69908021T patent/DE69908021T2/de not_active Expired - Lifetime
- 1999-06-08 AT AT99304451T patent/ATE240732T1/de active
- 1999-06-09 AU AU33983/99A patent/AU753820B2/en not_active Ceased
- 1999-06-09 TW TW088109645A patent/TW590774B/zh not_active IP Right Cessation
- 1999-06-09 SK SK769-99A patent/SK286245B6/sk not_active IP Right Cessation
- 1999-06-10 AP APAP/P/1999/001579A patent/AP1216A/en active
- 1999-06-10 SG SG1999002794A patent/SG77243A1/en unknown
- 1999-06-10 IL IL13042496A patent/IL130424A/xx not_active IP Right Cessation
- 1999-06-11 AR ARP990102822A patent/AR015553A1/es active IP Right Grant
- 1999-06-11 MY MYPI99002412A patent/MY121397A/en unknown
- 1999-06-11 IS IS5079A patent/IS2182B/is unknown
- 1999-06-11 CA CA002274338A patent/CA2274338C/en not_active Expired - Lifetime
- 1999-06-11 PE PE1999000523A patent/PE20000632A1/es not_active Application Discontinuation
- 1999-06-11 TR TR1999/01379A patent/TR199901379A2/xx unknown
- 1999-06-14 HU HU9901960A patent/HU226487B1/hu not_active IP Right Cessation
- 1999-06-14 CZ CZ0212799A patent/CZ297954B6/cs not_active IP Right Cessation
- 1999-06-14 HR HR990193A patent/HRP990193B1/xx not_active IP Right Cessation
- 1999-06-14 CN CNB991111192A patent/CN1307994C/zh not_active Expired - Fee Related
- 1999-06-14 NZ NZ336271A patent/NZ336271A/xx not_active IP Right Cessation
- 1999-06-14 NO NO19992892A patent/NO316713B1/no not_active IP Right Cessation
- 1999-06-14 ID IDP990571D patent/ID23546A/id unknown
- 1999-06-14 OA OA9900126A patent/OA11064A/en unknown
- 1999-06-14 UA UA99063279A patent/UA59383C2/uk unknown
- 1999-06-14 JP JP16677399A patent/JP3441676B2/ja not_active Expired - Lifetime
- 1999-06-14 PA PA19998475601A patent/PA8475601A1/es unknown
- 1999-06-14 PL PL333737A patent/PL195209B1/pl not_active IP Right Cessation
- 1999-06-14 RS YUP-271/99A patent/RS49611B/sr unknown
- 1999-06-14 KR KR1019990021977A patent/KR100338915B1/ko not_active Expired - Fee Related
- 1999-06-14 BG BG103489A patent/BG64691B1/bg unknown
- 1999-06-14 PL PL380276A patent/PL195606B1/pl not_active IP Right Cessation
- 1999-06-14 ZA ZA9903938A patent/ZA993938B/xx unknown
- 1999-06-14 MA MA25621A patent/MA26647A1/fr unknown
- 1999-06-15 BR BR9902268-0A patent/BR9902268A/pt not_active Application Discontinuation
- 1999-06-15 EA EA199900467A patent/EA002223B1/ru not_active IP Right Cessation
- 1999-06-15 CO CO99037319A patent/CO5070579A1/es unknown
- 1999-08-10 UY UY25649A patent/UY25649A1/es unknown
2001
- 2001-06-11 JP JP2001175276A patent/JP4187423B2/ja not_active Expired - Lifetime
2003
- 2003-11-20 CY CY200300002C patent/CY2003002I1/el unknown

Also Published As

Publication number	Publication date
PA8475601A1 (es)	2000-09-29
UA59383C2 (uk)	2003-09-15
CN1242987A (zh)	2000-02-02
UY25649A1 (es)	2000-02-23
EA199900467A2 (ru)	1999-12-29
YU27199A (sh)	2002-12-10
EP0965343B1 (en)	2003-05-21
AP1216A (en)	2003-10-19
SK76999A3 (en)	2000-12-11
NO992892D0 (no)	1999-06-14
TR199901379A2 (xx)	2000-01-21
EA199900467A3 (ru)	2000-04-24
NO992892L (no)	1999-12-16
IS5079A (is)	1999-12-16
NZ336271A (en)	2000-10-27
CY2003002I1 (el)	2009-11-04
GT199900080A (es)	2000-11-29
PT965343E (pt)	2003-08-29
HN1999000089A (es)	1999-11-03
CO5070579A1 (es)	2001-08-28
IL130424A0 (en)	2000-06-01
HRP990193B1 (en)	2003-08-31
HU226487B1 (en)	2009-03-02
HUP9901960A2 (hu)	2000-08-28
JP3441676B2 (ja)	2003-09-02
NO316713B1 (no)	2004-04-13
TW590774B (en)	2004-06-11
CN1307994C (zh)	2007-04-04
DK0965343T3 (da)	2003-08-04
US6150366A (en)	2000-11-21
ZA993938B (en)	2000-12-14
SK286245B6 (sk)	2008-06-06
CZ212799A3 (cs)	2000-09-13
HUP9901960A3 (en)	2000-09-28
ATE240732T1 (de)	2003-06-15
PL195209B1 (pl)	2007-08-31
BG64691B1 (bg)	2005-12-30
CA2274338C (en)	2003-04-15
AU3398399A (en)	1999-12-23
IL130424A (en)	2003-10-31
MY121397A (en)	2006-01-28
PL333737A1 (en)	1999-12-20
AU753820B2 (en)	2002-10-31
HU9901960D0 (en)	1999-08-30
ES2197581T3 (es)	2004-01-01
OA11064A (en)	2002-03-13
ID23546A (id)	2000-05-04
PL195606B1 (pl)	2007-10-31
JP4187423B2 (ja)	2008-11-26
DE69908021D1 (de)	2003-06-26
PE20000632A1 (es)	2000-07-26
JP2000007566A (ja)	2000-01-11
BG103489A (en)	2000-07-31
CZ297954B6 (cs)	2007-05-09
AP9901579A0 (en)	1999-06-30
MA26647A1 (fr)	2004-12-20
EP0965343A3 (en)	2000-02-23
SI0965343T1 (en)	2003-10-31
AR015553A1 (es)	2001-05-02
JP2002003492A (ja)	2002-01-09
EP0965343A2 (en)	1999-12-22
CA2274338A1 (en)	1999-12-15
DE69908021T2 (de)	2003-11-27
EA002223B1 (ru)	2002-02-28
KR100338915B1 (ko)	2002-05-30
BR9902268A (pt)	2000-05-02
KR20000006143A (ko)	2000-01-25
SG77243A1 (en)	2000-12-19
RS49611B (sr)	2007-06-04
HRP990193A2 (en)	2000-02-29
HK1024184A1 (en)	2000-10-05

Publication	Publication Date	Title
DK0965343T3 (da)	2003-08-04	Ziprasidonformuleringer
IS5555A (is)	2000-06-30	Selekoxib lyfjablöndur
ID30031A (id)	2001-11-01	Formulasi-formulasi agrokimia
NO20004240L (no)	2000-10-18	Formuleringer
ATE224703T1 (de)	2002-10-15	Brauseformulierungen
PT1130966E (pt)	2005-04-29	Formulacoes antiparasitarias
PT1096937E (pt)	2005-04-29	Formulacoes de ranolazina de libertacao prolongada
DE69805443D1 (de)	2002-06-20	Sachet-formulierungen
MA24473A1 (fr)	1998-10-01	Formulations
ATE367793T1 (de)	2007-08-15	Schweisshemmende zusammensetzungen
ID29635A (id)	2001-09-06	Formulasi mikrokapsul
ID23458A (id)	2000-04-27	Bentuk sediaan nefazodon
DE69920073D1 (de)	2004-10-21	kinderschutzhöschen
CY2006006I1 (el)	2009-11-04	Πρωτεϊνικα σκευασματα
IS6398A (is)	2002-05-27	Lyfjablöndur
ATE357237T1 (de)	2007-04-15	Formulierungen enthaltend cefuroxim-axetil
ID27655A (id)	2001-04-19	Formulasi mikrokapsul
EP1192168A4 (en)	2003-04-16	galectin
ATA208398A (de)	1999-12-15	Handstück
SE9800170D0 (sv)	1998-01-22	Formulation
SE9800766D0 (sv)	1998-03-09	Formulation
ITPS990017V0 (it)	1999-05-19	Leeran 1 (lorean)
FI3880U1 (fi)	1999-04-12	Tarjoilusetti
SE9900910D0 (sv)	1999-03-11	FreezeBox 2000
SE9901602D0 (sv)	1999-05-04	Jet-tröska 2000